Gsa Capital Partners LLP Spring Works Therapeutics, Inc. Transaction History
Gsa Capital Partners LLP
- $1.32 Billion
- Q3 2024
A detailed history of Gsa Capital Partners LLP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 6,512 shares of SWTX stock, worth $247,521. This represents 0.02% of its overall portfolio holdings.
Number of Shares
6,512Holding current value
$247,521% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$255 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$214 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$146 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$134 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$130 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.37B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...